Inventor · disambiguated record
Martin Schwill
Also filed as: SCHWILL MARTIN
2 granted patents·5 pending applications·0 citations·filing 2013–2022
25Inventor score
Top patents by PatentIndex Score
7 records- 0159US2022135700A1Bispecific HER2 Ligands for Cancer TherapyUNIV ZUERICH·Filed 2022·Application pending·0 cites
- 0250US2024327394A1Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancerTOLREMO THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0347US12472179B2Combination of a CBP/p300 bromodomain inhibitor and a KRAS inhibitor for the treatment of cancerTOLREMO THERAPEUTICS AG·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 0447US10093740B2Bispecific HER2 ligands for cancer therapyUNIV ZUERICH·Filed 2013·Granted Oct 9, 2018·0 cites·22 claims
- 0547US2019127481A1Bispecific HER2 Ligands for Cancer TherapyUNIV ZUERICH·Filed 2018·Application pending·0 cites
- 0642US2021395396A1Her2-binding tetrameric polypeptidesUNIV ZUERICH·Filed 2019·Application pending·0 cites
- 0739US2023255966A1A combination of a cbp/p300 bromodomain inhibitor and an egfr inhibitor for use in treating egfr-mutant nsclcTOLREMO THERAPEUTICS AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Schwill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →